PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Basal Cell Carcinoma 7,953 Disease Target Renin 43,456 3 0.00 -1.00 0.00 0.50
Basal Cell Carcinoma 7,953 Disease Target BTK 1,263 1 0.00 -1.00 0.00 0.56
Basal Cell Carcinoma 7,953 Disease Target CXCL11 526 2 0.00 -1.00 0.00 0.59
Hormone Replacement Therapy 11,020 Disease Target Elastase 13,875 3 0.00 -1.00 0.00 0.52
Hormone Replacement Therapy 11,020 Disease Target BMP-2 3,889 1 0.00 -1.00 0.00 0.52
Basal Cell Carcinoma 7,953 Disease Target Cytokeratin 18 1,108 1 0.00 -1.00 0.00 0.56
Hormone Replacement Therapy 11,020 Disease Target Glutathione Peroxidase 3 132 1 0.00 -1.00 0.01 0.59
Hormone Replacement Therapy 11,020 Disease Target Cardiotrophin-1 351 1 0.00 -1.00 0.00 0.57
Basal Cell Carcinoma 7,953 Disease Target CXCL10 2,386 2 0.00 -1.00 0.00 0.56
Basal Cell Carcinoma 7,953 Disease Target BMP-2 3,889 1 0.00 -1.00 0.00 0.53
Basal Cell Carcinoma 7,953 Disease Target Elastase 13,875 5 0.00 -1.00 0.00 0.54
Basal Cell Carcinoma 7,953 Disease Target CD34 24,598 31 0.00 -1.00 0.00 0.59
Basal Cell Carcinoma 7,953 Disease Target BRAF 4,766 8 0.00 -1.00 0.00 0.59
Basal Cell Carcinoma 7,953 Disease Target BDNF 11,163 1 0.00 -1.00 0.00 0.50
Hormone Replacement Therapy 11,020 Disease Target Cytokeratin 18 1,108 1 0.00 -1.00 0.00 0.55
Aldactone (Spironolactone)- FDA 18 Drug Target Angiotensin Converting Enzyme 31,674 1 0.00 -0.97 0.06 0.60
Aldactone (Spironolactone)- FDA 18 Drug Target Aldosterone Receptor 528 1 0.01 -0.97 0.06 0.71
Basal Cell Carcinoma 7,953 Disease Target bFGF 9,327 6 0.00 -1.00 0.00 0.56
Aldactone (Spironolactone)- FDA 18 Drug Target CHK2 1,391 1 0.01 -0.97 0.06 0.68
Aldactone (Spironolactone)- FDA 18 Drug Target Renin 43,456 1 0.00 -0.97 0.06 0.59
Acne 11,364 Disease Target Angiotensin Converting Enzyme 31,674 2 0.00 -1.00 0.00 0.48
Acne 11,364 Disease Target C5a 4,164 4 0.00 -1.00 0.00 0.56
Basal Cell Carcinoma 7,953 Disease Target BMP-6 386 1 0.00 -1.00 0.00 0.58
Basal Cell Carcinoma 7,953 Disease Target Insulin-Like Growth Factor 1 Receptor 1,052 1 0.00 -1.00 0.00 0.56
Alpha-Glucosidase 4,319 Target Target Pancreatic Alpha-Amylase 423 56 0.04 -0.93 0.13 0.74
Alpha-Glucosidase 4,319 Target Target Elastase 13,875 11 0.00 -1.00 0.00 0.58
Alpha-Glucosidase 4,319 Target Target CA 50 1,293 1 0.00 -1.00 0.00 0.57
Acne 11,364 Disease Target Catechol O-Methyltransferase 2,877 1 0.00 -1.00 0.00 0.53
Alpha-Glucosidase 4,319 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.52
Acne 11,364 Disease Target Cathepsin G 1,613 2 0.00 -1.00 0.00 0.56
Acne 11,364 Disease Target Eotaxin 2,457 1 0.00 -1.00 0.00 0.53
Alpha-Glucosidase 4,319 Target Target Renin 43,456 2 0.00 -1.00 0.00 0.50
Alpha-Glucosidase 4,319 Target Target EGF 27,487 3 0.00 -1.00 0.00 0.52
Alpha-Glucosidase 4,319 Target Target Cytokeratin 8 587 1 0.00 -1.00 0.00 0.59
Alpha-Glucosidase 4,319 Target Target Platelet Activating Factor 9,915 1 0.00 -1.00 0.00 0.52
Alpha-Glucosidase 4,319 Target Target Sphingomyelinase 3,060 9 0.00 -1.00 0.00 0.63
Acne 11,364 Disease Target Steroid 5-Alpha-Reductase 293 4 0.00 -0.99 0.01 0.62
Alpha-Glucosidase 4,319 Target Target C7 7,027 4 0.00 -1.00 0.00 0.57
Alpha-Glucosidase 4,319 Target Target Exendin-4 855 1 0.00 -1.00 0.00 0.58
Alpha-Glucosidase 4,319 Target Target Lysosomal Alpha-Glucosidase 105 105 0.16 -0.10 1.00 0.79
Alpha-Glucosidase 4,319 Target Target Cox-2 21,583 3 0.00 -1.00 0.00 0.53
Alpha-Glucosidase 4,319 Target Target BCHE 1,167 2 0.00 -1.00 0.00 0.60
Alpha-Glucosidase 4,319 Target Target Collagen 138,882 21 0.00 -1.00 0.00 0.53
Draflazine 33 Drug Target Adenosine Deaminase 6,613 2 0.00 -0.97 0.06 0.65
Acne 11,364 Disease Target Erbb2 4,536 1 0.00 -1.00 0.00 0.52
Basal Cell Carcinoma 7,953 Disease Target EDF 379 1 0.00 -1.00 0.00 0.58
Basal Cell Carcinoma 7,953 Disease Target AFP 9,751 2 0.00 -1.00 0.00 0.53
Basal Cell Carcinoma 7,953 Disease Target ERK1 18,374 6 0.00 -1.00 0.00 0.54
Basal Cell Carcinoma 7,953 Disease Target ETS1 539 1 0.00 -1.00 0.00 0.57
Acne 11,364 Disease Target Calmodulin 25,240 1 0.00 -1.00 0.00 0.47
Glucagon Receptor 537 Target Target Elastase 13,875 2 0.00 -1.00 0.00 0.58
Glucagon Receptor 537 Target Target EGF 27,487 1 0.00 -1.00 0.00 0.54
Glucagon Receptor 537 Target Target Sphingomyelinase 3,060 1 0.00 -1.00 0.00 0.60
Glucagon Receptor 537 Target Target Exendin-4 855 4 0.01 -0.99 0.01 0.69
Glucagon Receptor 537 Target Target DMPK 609 1 0.00 -1.00 0.00 0.65
Glucagon Receptor 537 Target Target Adenosine Deaminase 6,613 1 0.00 -1.00 0.00 0.58
Glucagon Receptor 537 Target Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.56
Glucagon Receptor 537 Target Target Adiponectin 11,994 3 0.00 -1.00 0.01 0.59
Glucagon Receptor 537 Target Target ERK1 18,374 3 0.00 -1.00 0.01 0.58
Kadsulignan L 3 Drug Target Platelet Activating Factor 9,915 1 0.01 -0.82 0.33 0.65
Acne 11,364 Disease Target CD14 9,941 7 0.00 -1.00 0.00 0.55
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
Eating Disorders 9,000 Disease Target BDNF 11,163 44 0.00 -1.00 0.00 0.63
Glomerulonephritis 23,459 Disease Target APOE 12,771 8 0.00 -1.00 0.00 0.53
Glomerulonephritis 23,459 Disease Target Antithrombin 13,773 29 0.00 -1.00 0.00 0.57
Graft Versus Host Disease 15,741 Disease Target Dihydrofolate Reductase 5,563 2 0.00 -1.00 0.00 0.52
Osteoporosis 46,215 Disease Target Bivalirudin 891 2 0.00 -1.00 0.00 0.54
Osteoporosis 46,215 Disease Target CD146 729 5 0.00 -1.00 0.01 0.56
Osteoporosis 46,215 Disease Target Endothelin A Receptor 722 2 0.00 -1.00 0.00 0.54
Osteoporosis 46,215 Disease Target Dna Polymerase I 1,993 1 0.00 -1.00 0.00 0.50
Graft Versus Host Disease 15,741 Disease Target Ricin 3,034 40 0.01 -0.99 0.01 0.64
Osteoporosis 46,215 Disease Target CER 2,421 4 0.00 -1.00 0.00 0.53
Graft Versus Host Disease 15,741 Disease Target CCL27/CTACK 5 1 0.00 -0.89 0.20 0.63
Osteoporosis 46,215 Disease Target BMP-7 1,112 16 0.00 -0.99 0.01 0.59
Graft Versus Host Disease 15,741 Disease Target CCL2 3,560 14 0.00 -1.00 0.00 0.59
Osteoporosis 46,215 Disease Target APOE 12,771 32 0.00 -1.00 0.00 0.55
Osteoporosis 46,215 Disease Target CHK1 2,044 1 0.00 -1.00 0.00 0.50
Osteoporosis 46,215 Disease Target ALK Phos 19 2 0.00 -0.95 0.11 0.61
Osteoporosis 46,215 Disease Target ERK2 3,287 1 0.00 -1.00 0.00 0.49
Osteoporosis 46,215 Disease Target Antithrombin 13,773 20 0.00 -1.00 0.00 0.53
Graft Versus Host Disease 15,741 Disease Target Antithrombin 13,773 12 0.00 -1.00 0.00 0.55
Graft Versus Host Disease 15,741 Disease Target Glutathione S-Transferase A1 111 1 0.00 -1.00 0.01 0.59
Graft Versus Host Disease 15,741 Disease Target Adenosine Deaminase 6,613 18 0.00 -1.00 0.00 0.59
Graft Versus Host Disease 15,741 Disease Target COP-1 118 1 0.00 -1.00 0.01 0.59
Graft Versus Host Disease 15,741 Disease Target APOA1 958 1 0.00 -1.00 0.00 0.54
Graft Versus Host Disease 15,741 Disease Target EDF 379 1 0.00 -1.00 0.00 0.56
Osteoporosis 46,215 Disease Target Sphingomyelinase 3,060 4 0.00 -1.00 0.00 0.53
Graft Versus Host Disease 15,741 Disease Target Insulin-Like Growth Factor 1 Receptor 1,052 1 0.00 -1.00 0.00 0.54
Osteoporosis 46,215 Disease Target C7 7,027 19 0.00 -1.00 0.00 0.55
Graft Versus Host Disease 15,741 Disease Target BMP-6 386 1 0.00 -1.00 0.00 0.56
Osteoporosis 46,215 Disease Target Exendin-4 855 2 0.00 -1.00 0.00 0.54
Graft Versus Host Disease 15,741 Disease Target Phospholipase A2 13,400 1 0.00 -1.00 0.00 0.48
Osteoporosis 46,215 Disease Target AHSG 176 7 0.00 -0.98 0.04 0.60
Osteoporosis 46,215 Disease Target Carbonic Anhydrase 3 36 1 0.00 -0.99 0.03 0.58
Osteoporosis 46,215 Disease Target Cox-2 21,583 48 0.00 -1.00 0.00 0.55
Graft Versus Host Disease 15,741 Disease Target Xanthine Oxidase 8,860 1 0.00 -1.00 0.00 0.49
Osteoporosis 46,215 Disease Target CD95 4,266 3 0.00 -1.00 0.00 0.51
Graft Versus Host Disease 15,741 Disease Target Methylenetetrahydrofolate Reductase 3,573 10 0.00 -1.00 0.00 0.58
Osteoporosis 46,215 Disease Target Arachidonate 5-Lipoxygenase 170 1 0.00 -1.00 0.01 0.55